ArticleAntimicrobial agents and chemotherapy2019

Resistance Analysis of Bictegravir-Emtricitabine-Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients through 48 Weeks.

Rima K Acosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.